Coping with Viral Diversity in HIV Vaccine Design. - David C. Nickle; Morgane Rolland; Mark A. Jensen; Sergei L. Kosakovsky Pond; Wenjie Deng; Mark Seligman; David Heckerman; James I. Mullins; Nebojsa Jojic (PLoS Comput. Biol., 2007)

Comparison of Immunogen Designs That Optimize Peptide Coverage: Reply to Fischer et al. - David C. Nickle; Nebojsa Jojic; David Heckerman; Vladimir Jojic; Darko Kirovski; Morgane Rolland; Sergei L. Kosakovsky Pond; James I. Mullins (PLoS Comput. Biol., 2008)

: Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial. - Paul Thatcher Edlefsen; Morgane Rolland; Tomer Hertz; Sodsai Tovanabutra; Andrew J. Gartland; Allan C. deCamp; Craig A. Magaret; Hasan Ahmed; Raphael Gottardo; Michal Juraska; Connor McCoy; Brendan B. Larsen; et al. (PLoS Comput. Biol., 2015)

The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes. - Hongjun Bai; Yifan Li 008; Nelson Michael; Merlin L. Robb; Morgane Rolland (PLoS Comput. Biol., 2019)

Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials. - Daniel B. Reeves; Yunda Huang; Elizabeth R. Duke; Bryan T. Mayer; E. Fabian Cardozo-Ojeda; Florencia A. Boshier; David A. Swan; Morgane Rolland; Merlin L. Robb; John R. Mascola; Myron S. Cohen; Lawrence Corey; et al. (PLoS Comput. Biol., 2020)

Factors influencing estimates of HIV-1 infection timing using BEAST. - Bethany L. Dearlove; Sodsai Tovanabutra; Christopher L. Owen; Eric Lewitus; Yifan Li 008; Eric Sanders-Buell; Meera Bose; Anne-Marie O'Sullivan; Gustavo Kijak; Shana Miller; Kultida Poltavee; Jenica Lee; et al. (PLoS Comput. Biol., 2021)

Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens. - Eric Lewitus; Jennifer Hoang; Yifan Li 008; Hongjun Bai; Morgane Rolland (PLoS Comput. Biol., 2022)